Cyclical excitability of the motor cortex in patients with catamenial epilepsy: A transcranial magnetic stimulation study  by Hattemer, Katja et al.
Seizure (2006) 15, 653—657
www.elsevier.com/locate/yseizCASE REPORT
Cyclical excitability of the motor cortex in patients
with catamenial epilepsy: A transcranial magnetic
stimulation study
Katja Hattemer *, Susanne Knake, Janine Reis, Wolfgang H. Oertel,
Felix Rosenow, Hajo M. HamerInterdisciplinary Epilepsy Center, Department of Neurology, Philipps-University Marburg,
Rudolf-Bultmann-Str. 8, 35033 Marburg, Germany








Purpose: The pathophysiology of catamenial epilepsy is still unclear. Therefore, we
investigated the cortical excitability of women with catamenial epilepsy during
different phases of the menstrual cycle.
Methods: Using transcranial magnetic stimulation, six patients suffering from cata-
menial epilepsy were investigated during ovulatory cycles. On days 8, 14, 7 and 2
of the cycle (day 1 being the first day of menstrual bleeding), resting motor threshold
(RMT), cortical silent period (CSP), intracortical inhibition (ICI) and intracortical
facilitation (ICF) were investigated. The non-parametric Friedman-test for multiple
comparisons and Wilcoxon signed rank test were used for statistical analysis.
Results: Five patients suffered from focal epilepsy (three right hemispheric, one
bitemporal, one unknown origin) and one patient had idiopathic generalized epilepsy.
All patients experienced perimenstrual seizure clustering and two also showed an
increased seizure frequency during the luteal phase. In the right hemispheres there
was a significant change of CSP duration in the course of themenstrual cycle (x2 = 8.3,
P = 0.041), due to a shorter CSP during the luteal phase (Z = 2.0, P = 0.043) and
menstruation (Z = 2.2, P = 0.028) as compared to the follicular phase. There was no
significant variation of CSP in the left hemispheres. RMT, ICI and ICF showed no
significant changes in the course of the menstrual cycle.
Conclusions: The CSP changes suggest a decreased inhibition involving GABA-ergic
neurotransmission during the luteal phase and menstruation. These TMS alterations
correlated with the clinical course of the epilepsies and were found in the hemi-
spheres containing the majority of the epileptogenic zones.
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About one-third of women suffering from epilepsy
experience catamenial seizure exacerbation.1
Results of animal studies suggested that cyclical
seizure clustering is caused by fluctuations of female
sexual steroids and their effects on the GABA-ergic
system.2—4 The pathophysiology underlying cyclical
seizure clusters in human epilepsy is still unclear and
only few studies confirmed cyclical changes of GABA-
ergic transmission in healthy women.5,6
Multiparametric transcranial magnetic stimula-
tion (TMS) offers the opportunity to separately
examine excitatory and inhibitory functions of the
motor cortex on different days of the menstrual
cycle5 and can, therefore, be used to detect cyclical
changes in the excitability of the primary motor
area.
In order to explore changes in cortical excitability
underlying catamenial seizure exacerbation, we
applied multiparametric TMS to patients with cat-
amenial epilepsy during different phases of their
menstrual cycle.Methods
Patients
Over a 2-year period (2004—2005), we included six
female epileptic patients in their reproductive age
according to the following criteria of eligibility.
Inclusion criteria
(1) Catamenial epilepsy defined as doubling of sei-
zure frequency during one or two of the four
cycle phases (follicular phase: day 4 to day 9
(day 1 being the first day of menstrual bleeding);
ovulation: day 10 to day13 (13 days before the
onset of the following menstrual bleeding);
luteal phase: day 12 to day 4; menstruation:
day 3 to day 3 of the following menstrual
cycle1) as compared to the remaining phases
observed at least for the last 12 months.(2) Active epilepsy defined as at least one seizure
per month over the last 6 months.(3) 18—40 years of age.
(4) Regular menstrual cycle of 25—30 days during
the last six cycles.
(5) Right-handedness.Exclusion criteria
(1) Menstrual-related affective disorders.
(2) Use of hormonal contraceptive methods, preg-
nancy, lactation period.(3) Fluctuation of cycle length of more than1 day.
(4) History of ovarectomy.
(5) Endocrinological abnormalities (such as
hyperthyroidism or hyperandrogenaemia).
(6) Cardiac pacemaker, vagal nerve stimulator or
intracranial metal implantates.
(7) History of previous neurosurgery or fracture of
the skull.
(8) No change of the anticonvulsant medication for
at least 3 months before and during the cycle
tested.All patients provided written informed consent
after a detailed explanation of the experimental
testing. The study conformed to the standards set by
the Declaration of Helsinki and had the approval of
the local Ethics Committee.
Estradiol and luteinizing hormone (LH) were
tested on day 14, at the assumed time of their
peak causing ovulation. Progesterone levels were
measured during the luteal phase on day 7. A
menstrual cycle was classified as ovulatory when
progesterone levels exceeded 5 ng ml1.1
Methods
All patients were investigated on day 8 (follicular
phase), day 14 (ovulation), day 7 (luteal phase)
and day 2 (menstruation of the following menstrual
cycle).1
Single- and paired-pulse transcranial magnetic
stimulation was delivered through a figure-of-eight
shaped magnetic coil following a protocol described
in detail elsewhere.7 The following TMS parameters
were evaluated in both hemispheres.
The resting motor threshold (RMT) was defined as
the minimal stimulus intensity required to induce a
MEPof more than 50 mV peak-to-peak amplitude in a
relaxed muscle in at least five out of 10 consecutive
trials. Intracortical inhibition (ICI) and facilitation
(ICF) were obtained by paired-pulse paradigms at
short interstimulus intervals (ISI) of 2 and 3 ms (ICI)
and longer interstimulus intervals of 10 and 15 ms
(ICF),7 respectively. The conditioning stimulus was
set to an intensity of 75% of RMT, the intensity of the
following test stimulus was adjusted to produce
MEPs of an approximately 1.5 mV peak-to-peak
amplitude at rest. One parameter for ICI was cre-
ated by averaging the values obtained by ISI 2 and
3 ms for each woman and ICF was defined as the
average of the values of ISI 10 and 15 ms.
The cortical silent period (CSP) wasmeasured at a
stimulus intensity of 110% of the RMT. The subjects
were instructed to hold a voluntary muscle contrac-
tion of approximately 30% of the maximal force. The
CSP duration was defined as the time interval from
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Table 1 Clinical characteristics of patients
Patient Epilepsy
syndrome
Side Medication EEG MRI Seizure
exacerbation
1 TLE Bilateral CBZ, LEV, LTG Bitemporal SP;
bitemporal SW
Bilateral HS Perimenstrual
2 Focal Unknown CBZ, VPA Left temporal IS Unremarkable Perimenstrual
and ovulatory





4 IGE n.a. ESM, VPA Generalized SWC Unremarkable Perimenstrual




6 TLE Right LTG, TPM Right temporal SP;
bitemporal SW
Right HS Luteal and
perimenstrual
FLE: frontal lobe epilepsy, IGE: idiopathic generalized epilespy, TLE: temporal lobe epilepsy.
n.a.: not applicable.
ESM: Ethosuximid, CLB: Clobazam, CBZ: Carbamazepine, LEV: Levetiracetam, LTG: Lamotrigine, TPM: Topiramate, VPA: Valproate.
IS: intermittent slow, SP: seizure pattern, SW: sharp waves, SWC: spike and wave complex.
HS: hippocampal sclerosis.the beginning of the stimulus induced MEP to the
first recurrence of voluntary EMG activity.
Statistical analysis
The non-parametric Friedman test for multiple com-
parisons was used for statistical analysis. Significant
results were further analysed using the Wilcoxon
signed rank test. In this exploratory study, the level
of significance of each comparison was set to
P < 0.05. Left and right hemispheres were analysed
separately.Results
Six patients with catamenial epilepsy and ovulatory
cycles (age: 38.7  7.8 years, cycle length:
28.0  2.2 days, estrogen levels on day 14:
114.7  55.6 pg ml1, progesterone levels on day
7: 8.3  3.8 ng ml1) were included. For patientTable 2 TMS-parameters in the course of the menstrual c
CSP: cortical silent period; RMT: resting motor threshold; ICI: intrac
stimulator output; TR: test response.
: P < 0.05.characteristics see Table 1. During the cycle stu-
died, patients 3, 5 and 6 showed their usual course
of seizure frequency, patient 1 had four out of eight
seizures perimenstrually and patients 2 and 4 were
seizure free.
In the right hemispheres there was a significant
change of CSP in the course of the menstrual cycle
(x2 = 8.3, P = 0.041), due to a shorter CSP during the
luteal phase (Z = 2.0, P = 0.043) and menstruation
(Z = 2.2, P = 0.028) as compared to the follicular
phase (Table 2; Fig. 1). Resting motor threshold
(x2 = 1.3, P = 0.73), ICI (x2 = 3.4, P = 0.33) and ICF
(x2 = 0.60, P = 0.90) did not show significant changes
during the menstrual cycle.
There were no significant changes of any of the
TMS-parameters in the left hemispheres (CSP:
x2 = 1.8, P = 0.62; RMT: x2 = 4.1, P = 0.25; ICI:
x2 = 2.6, P = 0.46; ICF: x2 = 1.4, P = 0.71; Table 2)
and neither comparing the left with right hemi-
spheres for any of the TMS-parameters. Three
patients suffered from focal epilepsy with an epi-ycle
ortical inhibition; ICF: intracortical facilitation; MSO: maximal
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Figure 1 Duration of the cortical silent period (in ms) in
the course of the menstrual cycle; Line: median, boxes:
25—75% quartiles, whisker: maximum and minimum, (*)
P < 0.05, (**) Friedman test: x2 = 8.3, P = 0.041.leptogenic zone restricted to one hemisphere
(patients 3, 5 and 6). The median (range) of the
CSP in the ipsilateral, right hemispheres was lower
as compared to the contralateral, left hemispheres
at all four testings with a maximal difference at day
7 (ipsilateral: day 8: 170 ms (161—254 ms), day
14: 175 ms (168—215 ms), day 7: 160 ms (153—
169 ms), day 2: 154 ms (120—215 ms); contralateral:
day 8: 189 ms (112—259 ms), day14: 192 ms (154—
227 ms), day 7: 211 ms (129—222 ms), day 2:
163 ms (106—232 ms)).Discussion
In the present study, the excitability of the motor
cortex was assessed by TMS during ovulatory cycles
in patients with catamenial epilepsy. Only women
with stable cycles were included to obtain a homo-
geneous patient group. The cortical silent period
was shortened during the luteal phase and men-
struation as compared to the follicular phase.
This correlated well with the history of peri-
menstrual seizure clustering in all and luteal sei-
zure clustering in two of the six patients included
in this study.
In four of the six patients, the right hemisphere
harboured the epileptogenic zone8 in whole or in
part. In contrast, only one patient may have had
the epileptogenic zone exclusively in the left
hemisphere (patient with focal epilepsy of
unknown origin). The CSP alteration was observed
only in patients’ right but not in the left hemi-
spheres. There is evidence that focal epilepsies
influence chronically the ipsilateral motor cortex,leading to a decreased inhibition seen as shortened
CSP even when the epileptogenic zone is apart
from it.7,9 This alteration was attributed to synap-
tic reorganization involving GABAB-ergic neuro-
transmission. It can be hypothesized from the
present results that ipsilateral cortex altered by
focal epilepsies responds differently to cyclical
hormonal fluctuations as compared to unaffected
contralateral cortex, hence facilitating catame-
nial changes in seizure threshold. This could
explain the finding that the CSP alteration in the
present study was seen in right hemispheres only,
which contained the majority of the focal epilep-
sies and the active focus of all patients who
showed their usual catamenial seizure exacerba-
tion during the cycle studied.
Hormonal effects
In animal studies, estrogens were reported to
increase and progesterone to inhibit cortical excit-
ability and cause cyclical changes in seizure suscept-
ibility.2—4 It remained unclear whether these results
are the cause of the cyclical changes in human
epilepsy.
As compared to the follicular phase, our results
showed a shorter CSP during the luteal phase, when
both estrogen and progesterone levels are ele-
vated.1 This supports the view of an excitatory
effect of estrogens on cortical excitability. The
decreased progesterone to estradiol ratio found in
patients with epilepsy may also play a role.10,11 The
decrease in CSP during menstruation may be caused
by falling progesterone levels.1 Even though estro-
gen levels peak before ovulation, there was no
significant shortening of the silent period at ovula-
tion. This may be due to the short duration of the
estrogen peak,1 which has possibly been missed at
our testing on day 14 (ovulation) in some of the
patients, as suggested by the relatively low serum
estrogen levels in this study.1 Reflecting the
unchanged CSP at ovulation, it is noteworthy that
only one woman in the present study showed peri-
ovulatory seizure clustering.Conclusions
The results of the present TMS study on women with
catamenial epilepsy revealed a shortened CSP dur-
ing the luteal phase and menstruation which corre-
lated well with the clinical course of the catamenial
epilepsies included. The CSP alterations were found
in the hemispheres which contained the majority of
the epileptogenic zones. This may indicate an
altered responsiveness of GABA-ergic transmission
TMS in catamenial epilepsy 657to sexual hormones in epileptic hemispheres leading
to cyclical changes in seizure threshold.
Future studies on larger patients groups with
more homogeneous epilepsy syndromes are war-
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